1nKemia IUCT Group, S.A.

IKM

ES0156303002

Pharmaceuticals

Market Closed - BME Other stock markets 10:00:18 2024-05-10 am EDT			5-day change	1st Jan Change
0.31 ^EUR	0.00%		0.00%	0.00%

Apr. 30	1nKemia IUCT Group, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
2020	Crescent Hill Capital Corporation cancelled the acquisition of unknown stake in 1nKemia IUCT Group, S.A..	CI

1nKemia IUCT Group, S.A. announced that it expects to receive €3.8 million in funding

June 14, 2016

1nKemia IUCT Group, S.A. (BME:IKM) announced that it will receive €3.8 million in equity funding on June 15, 2016. The transaction has been approved by board of directors of the company.

Latest news about 1nKemia IUCT Group, S.A.

1nKemia IUCT Group, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	Apr. 30	CI
Crescent Hill Capital Corporation cancelled the acquisition of unknown stake in 1nKemia IUCT Group, S.A..	20-07-18	CI
Unknown buyer acquired unknown stake in Leanbio SL from 1nKemia IUCT Group, S.A. for €0.32 million.	19-12-05	CI
An undisclosed buyer acquired Institut Univ. de Ciència i Tecnología, S.A from 1nKemia IUCT Group, S.A..	19-09-26	CI
Crescent Hill Capital Corporation signed an letter of intent to acquire unknown stake in 1nKemia IUCT Group, S.A..	19-07-18	CI
An unknown buyer acquired Joaquin Riera Tuebols S.A. and Laboratorio Micro-Bios, S.L. from 1nKemia IUCT Group, S.A. for €0.1 million.	19-06-28	CI
Phyture Biotech S.L. announced that it has received €0.61 million in funding from 1nKemia IUCT Group, S.A.	17-10-28	CI
Phyture Biotech S.L. announced that it expects to receive €0.55 million in funding from 1nKemia IUCT Group, S.A.	17-07-29	CI
Arkyne Technologies announced that it has received €0.25 million in funding from 1nKemia IUCT Group, S.A., Escola Sant Gervasi, SCCL, and other investors	16-12-27	CI
1nKemia IUCT Group, S.A. acquired 27% stake in Barcelona Ciencia Capilar for € 0.02 million.	16-06-20	CI
1nKemia IUCT Group, S.A. announced that it expects to receive €3.8 million in funding	16-06-14	CI
1nkemia Reportedly Seeking To Sell UK unit	16-06-06	CI
1nKemia IUCT Group, S.A. cancelled the acquisition of Labsa, S.L.	15-09-30	CI
1nKemia IUCT Group, S.A. entered into an agreement to acquire Laboratorio de Seguridad Alimentaria.	14-09-30	CI
Inkemia Opens Brazilian Subsidiary 'Inkemia IUCT Group Tecnologia'	14-05-01	CI
Inkemia Plans to Open Subsidiary in Brazil in 2014	13-12-09	CI
1nKemia IUCT Mulls Acquisitions	13-10-09	CI
InKemia IUCTgroup S.A. announced that it has received €2.50 million in funding.	13-08-07	CI
InKemia IUCTgroup S.A. announced that it expects to receive €2.50 million in funding.	13-04-25	CI
1Nkemia IUCT Group, SA has completed an IPO in the amount of €1.30 million.	12-12-06	CI
1Nkemia IUCT Group, SA has filed an IPO in the amount of €1.30 million.	12-11-26	CI

Chart 1nKemia IUCT Group, S.A.

Duration

Period

More charts

Inkemia IUCT Group SA is a Spain-based company primarily specialized in the biotechnological sector. The Company provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Companyâs activity is related to the generation, promotion, development and sale of products and services. The Company transforms its knowledge and know-how into a pipeline of products, processes, services and technological platforms. Its solutions are specialized, integrated and protected by patents. The main areas of expertise are related to drugs development, industrial biotechnology and green chemistry. The Company has a number of subsidiaries, including IUCT SA and IUCT Empren SL.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
1NKEMIA IUCT GROUP, S.A.	0.00%	8.98M
CSL LIMITED	-2.61%	89.08B
SAMSUNG BIOLOGICS CO.,LTD.	+3.55%	40.9B
BIOGEN INC.	-14.40%	32.25B
UCB	+55.89%	25.14B
BIOMARIN PHARMACEUTICAL INC.	-15.96%	15.39B
INCYTE CORPORATION	-15.50%	11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.29%	11.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.75%	11.64B
SWEDISH ORPHAN BIOVITRUM AB	+7.87%	9.03B

Biopharmaceuticals